PARIS--(BUSINESS WIRE)--Acticor Biotech, (ISIN: FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular ...

Brainomix, a global leader and pioneer of AI-powered imaging tools in stroke and lung fibrosis, today announced the deployment of its AI imaging platform, Brainomix 360 Stroke, throughout the West ...

The US-based healthcare system has implemented a digital solution to support stroke assessment in partnership with Brainomix ...

Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute and chronic neurological disorders, today announced its participation in the American Society for Experimental ...

Across hospitals and health systems, stroke care sits at the intersection of several pressures leaders know well: rising acuity, uneven access to specialty care, workforce constraints and growing ...

A stroke — either a blockage of blood flow to the brain or bleeding in the brain — is a medical emergency that requires immediate treatment. The two types of stroke are treated differently but can ...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance ...

The TESLA trial was unable to support a benefit to thrombectomy for stroke patients with large-core infarcts identified on noncontrast CT within 24 hours. Unlike other studies, endovascular therapy in ...

Stroke remains one of Malaysia’s most pressing health challenges, consistently ranking among the country’s top causes of ...

The clinical syndrome produced by a stroke is determined by the artery or arteries that are occluded. Blood is supplied to the brain by two major sets of arteries, the anterior and posterior ...

A new trial has shown a sizeable and significant benefit of endovascular thrombectomy in acute ischemic stroke patients with a large vessel occlusion and an established large infarct identified with ...

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and adults are among the major updates in the new 2026 Guideline for the Early ...